Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03049839
Other study ID # 55657
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2017
Est. completion date December 30, 2019

Study information

Verified date March 2019
Source Universidad del Norte
Contact Tania Acosta
Phone 00573106331321
Email tacosta@uninorte.edu.co
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main aim of this study is to evaluate the feasibility and effectiveness of a program for modifying lifestyles for diabetes prevention type 2 and control cardio-metabolic risk factors in adults with different categories of risk from the primary health care strategy.

The project will show the effect of these interventions for the first time in people With different risk of developing type 2 diabetes throughout the life in populations living in Colombia Located in 2 different cities, one of them in the interior of the country (districts of Bogota) and another in the north coast (districts of Barranquilla) .


Description:

Cardiovascular disease (CVD) and type 2 diabetes (T2D) are currently the public health problems fastest growing globally. According to the International Diabetes Federation (IDF) is estimated to have diabetes approximately 382 million people in the world. It is shown that early interventions in lifestyle can reduce the burden of type 2 diabetes and factors of cardiovascular modifiable risk.

This is an intervention study in cluster. 36-month integrated into 4 phases:

1. Design and adaptation of educational intervention

2. Population Screening

3. Stepwise intervention program

4. Evaluation results.

For population screening test FINDRISC validated for the Latin American population will be employed and a score of 12 will be considered as a cutoff to all who have a score equal to or greater than 12 (moderate or high risk) they perform a test oral glucose tolerance (OGTT) according to the results 3 groups will be established

- High risk group: Subjects with FINDRISC score ≥12 and impaired glucose tolerance (IGT)

- Moderate risk group: Subjects with FINDRISC score ≥12 and impaired fasting glucose or norm tolerant

- Low risk group: Subjects with FINDRISC score <12.

Intervention program: One year of duration, 3 types of programs are established.

- Lifestyle Intervention program_ Communitarian: Intervention program at Community level with Low risk group.

- Lifestyle Intervention program_ Informative: Program information intervention for the group with moderate risk.

- Lifestyle Intervention program_ structured: intervention program for members of high-risk group.

An evaluation of the different variables are studied at baseline and the final of the intervention in the three groups established.


Recruitment information / eligibility

Status Recruiting
Enrollment 650
Est. completion date December 30, 2019
Est. primary completion date October 30, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 80 Years
Eligibility Inclusion Criteria:

- People over age 30 years, residents within the perimeter of the conglomerate in the districts of Barranquilla and Bogota

- Wishing to participate and sign informed consent

Exclusion Criteria:

- DT2 known and / or treated

- History of diseases or events that prevent their participation

- Neurological disability that does not allow you to make own decisions

- Pregnant women

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Intervention_ S
One year Structured intervention program for members of high-risk group (Subjects with FINDRISC score =12 points and impaired glucose tolerance (IGT))
Intervention_ I
One year Informative intervention program for members of moderate risk group (People with normotolerant or impaired fasting glucose in the OGTT and a FINDRISC score =12 points)
Intervention_ C
One year, Intervention program at Community level. People with a FINDRISC less than 12 points

Locations

Country Name City State
Colombia Universidad Del Norte Barranquilla
Colombia Asociación Colombiana de Diabetes Bogota

Sponsors (1)

Lead Sponsor Collaborator
Universidad del Norte

Country where clinical trial is conducted

Colombia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Reduction of body weight average at year-end structured intervention compared with the baseline. Reduction of body weight in kilograms 12 Months
Secondary Reduction of fasting glucose level at year-end intervention program (all groups) compared with baseline. Reduction of fasting glucose level in mg/dl 12 Months
Secondary Reduction of 2-hour glucose level at year-end structured and informative intervention program compared with baseline. Reduction of 2-hour glucose level in mg/dl 12 Months
Secondary Reduced of waist circumference average at year-end structured intervention program compared with baseline. Reduction of waist circumference in centimeters 12 Months
See also
  Status Clinical Trial Phase
Completed NCT05424107 - A Mediterranean Intervention on Prediabetic Children N/A
Recruiting NCT02681887 - Effect of Melatonin on Cardiometabolic Risk- FULL Phase 3
Completed NCT04088461 - Effect of Linagliptin + Metformin on Patients Who do Not Achieve Normoglucemia With Metformine Phase 4
Recruiting NCT02561377 - Effect of Resistance Training on Metabolic Control and Outcome in Prediabetes (NMR-based Metabonomics) N/A
Completed NCT02678390 - Medium Chain Triglycerides and Aerobic Exercise on Ketone Production in Women With or Without Prediabetes N/A
Completed NCT02551640 - Improving Physical Activity Through a mHealth Intervention in Cardio-metabolic Risk Patients N/A
Completed NCT02459691 - Culturally-adapted Diabetes Prevention Lifestyle Intervention for Latinos (E-LITE Latinos) N/A
Completed NCT01479933 - Glucose Metabolism Effects of Vitamin D Supplementation in Prediabetes N/A
Completed NCT01671293 - Multicomponent Telecare Model for Supporting Prediabetes Patients N/A
Completed NCT00960973 - The Effect of Vitamin K Supplementation on Glucose Metabolism Phase 4
Completed NCT00455325 - Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS) Phase 2
Recruiting NCT05123963 - Restoring 24-hour Substrate Rhythmicity to Improve Glycemic Control by Timing of Lifestyle Factors N/A
Recruiting NCT05340868 - Genetics of the Acute Response to Oral Semaglutide N/A
Recruiting NCT04984421 - IMplementation of the Family Support PRogramme A Healthy School Start to Prevent OVErweight and Obesity (IMPROVE) N/A
Recruiting NCT04131582 - Effect of Empagliflozin + Linagliptin + Metformin + Lifestyle in Patients With Prediabetes Phase 3
Recruiting NCT04134650 - Effect of Low Dose Combination of Linagliptin + Metformin to Prevent Diabetes Phase 3
Recruiting NCT05347030 - Acupuncture for Impaired Glucose Tolerance in Overweight/Obese Population N/A
Completed NCT04074148 - Effectiveness of Diabetes Prevention Education Program on Diabetes Prevention Among Prediabetes Population in Nepal N/A
Recruiting NCT05050266 - Enhancing Mental and Physical Health of Women Veterans N/A
Completed NCT02684565 - Effects of Branch Chain Amino Acids on Glucose Tolerance in Obese Pre-Diabetic Subjects N/A